Abogen Biosciences

Fucheng, Shanxi, China

(207) 939-1665 ★

http://www.abogenbio.com/

Company profile

Abogen Biosciences company profile

Abogen Biosciences is a discovery stage biotechnology company focuses on developing nucleic acid-based (RNA and DNA) therapeutics for treatment of cancer and infectious diseases.

Business identity

Website: http://www.abogenbio.com/
Contact email: [email protected]
Phone number: (207) 939-1665
Operating status: Active
Company type: For Profit
Employee range: 00251-00500 employees
Founded: 2019-01-10

Headquarters

Headquarters: Fucheng, Shanxi, China
Country code: CN
Continent: Asia

Capital profile

Funding and company signals

Funding stage: Late Stage Venture
Funding rounds: 6
Total equity funding: $1.4B
Last funding: Series C / $300M / 2021-11-29
Last equity funding: Series C / $300M
Investors: 38
Lead investors: 11
Founders: 1
Articles: 8

Categories and groups

Biotechnology Life Science Therapeutics Biotechnology Health Care Science and Engineering

Founders and investors

Founders

Bo Ying

Lead investors

5Y CapitalBoyu CapitalGL Ventures LLCInvesco Private CapitalLilly Asia VenturesLoyal Valley CapitalPICC Capital Investment ManagementSDIC Venture CapitalSoftBank Vision FundTemasek HoldingsYF Capital

Investors

Gaorong CapitalHighlight CapitalHillhouse InvestmentQiming Venture PartnersTemasek Holdings

People at this company

Preview only. Contact details are available after you sign in.

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Shipment records and coverage can change as the dataset is updated.